Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts

Cohesin is a highly conserved ring-shaped complex involved in topologically embracing chromatids, gene expression regulation, genome compartmentalization, and genome stability maintenance. Genomic analyses have detected mutations in the cohesin complex in a wide array of human tumors. These findings...

Full description

Bibliographic Details
Main Authors: Maria Michela Pallotta, Maddalena Di Nardo, Antonio Musio
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/7/608
_version_ 1827286919188316160
author Maria Michela Pallotta
Maddalena Di Nardo
Antonio Musio
author_facet Maria Michela Pallotta
Maddalena Di Nardo
Antonio Musio
author_sort Maria Michela Pallotta
collection DOAJ
description Cohesin is a highly conserved ring-shaped complex involved in topologically embracing chromatids, gene expression regulation, genome compartmentalization, and genome stability maintenance. Genomic analyses have detected mutations in the cohesin complex in a wide array of human tumors. These findings have led to increased interest in cohesin as a potential target in cancer therapy. Synthetic lethality has been suggested as an approach to exploit genetic differences in cancer cells to influence their selective killing. In this study, we show that mutations in <i>ESCO1</i>, <i>NIPBL</i>, <i>PDS5B</i>, <i>RAD21</i>, <i>SMC1A</i>, <i>SMC3</i>, <i>STAG2</i>, and <i>WAPL</i> genes are synthetically lethal with stimulation of WNT signaling obtained following LY2090314 treatment, a GSK3 inhibitor, in several cancer cell lines. Moreover, treatment led to the stabilization of β-catenin and affected the expression of <i>c-MYC,</i> probably due to the occupancy decrease in cohesin at the <i>c-MYC</i> promoter. Finally, LY2090314 caused gene expression dysregulation mainly involving pathways related to transcription regulation, cell proliferation, and chromatin remodeling. For the first time, our work provides the underlying molecular basis for synthetic lethality due to cohesin mutations and suggests that targeting the WNT may be a promising therapeutic approach for tumors carrying mutated cohesin.
first_indexed 2024-04-24T10:48:08Z
format Article
id doaj.art-b52750eaa6894a518c5c106ebd7b0436
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-04-24T10:48:08Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-b52750eaa6894a518c5c106ebd7b04362024-04-12T13:16:32ZengMDPI AGCells2073-44092024-03-0113760810.3390/cells13070608Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer ContextsMaria Michela Pallotta0Maddalena Di Nardo1Antonio Musio2Institute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, ItalyInstitute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, ItalyInstitute for Biomedical Technologies (ITB), National Research Council (CNR), 56124 Pisa, ItalyCohesin is a highly conserved ring-shaped complex involved in topologically embracing chromatids, gene expression regulation, genome compartmentalization, and genome stability maintenance. Genomic analyses have detected mutations in the cohesin complex in a wide array of human tumors. These findings have led to increased interest in cohesin as a potential target in cancer therapy. Synthetic lethality has been suggested as an approach to exploit genetic differences in cancer cells to influence their selective killing. In this study, we show that mutations in <i>ESCO1</i>, <i>NIPBL</i>, <i>PDS5B</i>, <i>RAD21</i>, <i>SMC1A</i>, <i>SMC3</i>, <i>STAG2</i>, and <i>WAPL</i> genes are synthetically lethal with stimulation of WNT signaling obtained following LY2090314 treatment, a GSK3 inhibitor, in several cancer cell lines. Moreover, treatment led to the stabilization of β-catenin and affected the expression of <i>c-MYC,</i> probably due to the occupancy decrease in cohesin at the <i>c-MYC</i> promoter. Finally, LY2090314 caused gene expression dysregulation mainly involving pathways related to transcription regulation, cell proliferation, and chromatin remodeling. For the first time, our work provides the underlying molecular basis for synthetic lethality due to cohesin mutations and suggests that targeting the WNT may be a promising therapeutic approach for tumors carrying mutated cohesin.https://www.mdpi.com/2073-4409/13/7/608cohesinWNTβ-catenincancersynthetic lethalityLY2090314
spellingShingle Maria Michela Pallotta
Maddalena Di Nardo
Antonio Musio
Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
Cells
cohesin
WNT
β-catenin
cancer
synthetic lethality
LY2090314
title Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
title_full Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
title_fullStr Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
title_full_unstemmed Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
title_short Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts
title_sort synthetic lethality between cohesin and wnt signaling pathways in diverse cancer contexts
topic cohesin
WNT
β-catenin
cancer
synthetic lethality
LY2090314
url https://www.mdpi.com/2073-4409/13/7/608
work_keys_str_mv AT mariamichelapallotta syntheticlethalitybetweencohesinandwntsignalingpathwaysindiversecancercontexts
AT maddalenadinardo syntheticlethalitybetweencohesinandwntsignalingpathwaysindiversecancercontexts
AT antoniomusio syntheticlethalitybetweencohesinandwntsignalingpathwaysindiversecancercontexts